Page last updated: 2024-10-26

disulfiram and Inflammatory Breast Neoplasms

disulfiram has been researched along with Inflammatory Breast Neoplasms in 2 studies

Inflammatory Breast Neoplasms: Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, J1
Sauer, SJ1
Tarpley, M1
Vermeulen, P1
Rypens, C1
Van Laere, S2
Williams, KP1
Devi, GR2
Dewhirst, MW1
Allensworth, JL1
Evans, MK1
Bertucci, F1
Aldrich, AJ1
Festa, RA1
Finetti, P1
Ueno, NT1
Safi, R1
McDonnell, DP1
Thiele, DJ1

Other Studies

2 other studies available for disulfiram and Inflammatory Breast Neoplasms

ArticleYear
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
    Oncotarget, 2017, Apr-18, Volume: 8, Issue:16

    Topics: Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Culture Techniques; Cell Survival; Copper; Di

2017
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
    Molecular oncology, 2015, Volume: 9, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Copper; Disulfiram; Female; Humans; Inflammatory Breast Neo

2015